Standard cholesterol and triglyceride tests often fail to detect key risk factors for cardiovascular disease, the leading cause of death in the U.S.
Chronic, low-grade inflammation has emerged as a critical contributor to heart disease by activating plaque buildup and increasing artery damage. Inflammation damages blood vessels, promotes unstable plaque formation, and raises blood clot risks, all of which elevate heart attack and stroke chances.
Common causes of chronic inflammation include visceral fat, insulin resistance, smoking, poor sleep, chronic stress, and autoimmune conditions.
The American College of Cardiology now recommends testing inflammatory biomarkers like high-sensitivity C-reactive protein (hs-CRP) to better assess cardiovascular risk. Elevated hs-CRP levels can indicate heart disease risk even when cholesterol levels are normal, and statin treatment can reduce events in such cases.
Other important inflammatory markers include lipoprotein(a), remnant cholesterol, and white blood cell profiles, which provide additional insight into cardiovascular risk. Biomarker ratios such as LDL-C/ApoB, triglyceride/HDL-C, and neutrophil/lymphocyte ratio offer deeper understanding of lipid particle size, insulin resistance, and immune system balance related to heart disease risk.
Reducing inflammation to lower heart disease risk begins with lifestyle changes such as regular exercise, maintaining a healthy weight, getting adequate sleep, and consuming a diet rich in whole, minimally processed foods.
If inflammation remains high despite lifestyle improvements, doctors may prescribe medications like statins that address both cholesterol and inflammation.
Certain supplements can also help decrease inflammation, including omega-3 fatty acids (2-4 grams daily), curcumin (500-1,000 mg daily), magnesium (300-400 mg daily), vitamin D3 (2,000-5,000 IU daily), and coenzyme Q10 (100-300 mg daily). These supplements have been shown to reduce C-reactive protein (CRP), a key marker of inflammation, by varying degrees, potentially lowering cardiovascular risk.
Lifestyle modifications remain the primary strategy for managing inflammation, but some individuals may require medication or supplements under medical supervision. Regular monitoring of inflammation markers is crucial for comprehensive heart disease prevention and personalized treatment planning.
